JAMA Ophthalmology · 2013 · 101 citations · 18 references
MedicineInternal MedicineOphthalmologyDiabetologyOcular DiseaseVisual DisordersDiabetes MellitusDiabetic RetinopathyMacular DiseaseMacular DisordersVisual ImpairmentVisual Impairment EpidemiologyBarriers To Eye CareDiabetes Mellitus AssessmentDiagnostic Pupil DilationMacular Edema AssessmentMacular Edema EvaluationOcular Manifestations Of DiabetesVisual Impairment AssessmentVisual Impairment From Diabetic Retinopathy
IMPORTANCE: Thickening of the center of the retina, diabetic macular edema (DME), is the most common cause of visual loss due to diabetes mellitus. Treatment of DME has improved dramatically, and the prompt diagnosis of DME and referral of these patients have become more critical. Nonetheless, awareness of and care for DME in the US population is uncharacterized. OBJECTIVE: To characterize eye care and awareness of eye disease among persons with DME in the general US population. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional analysis of data from participants in the 2005 to 2008 National Health and Nutrition Examination Survey 40 years or older with diabetes mellitus and fundus photographs. MAIN OUTCOMES AND MEASURES: Among persons with DME, (1) awareness that diabetes has affected their eyes; (2) report on the last time they visited a diabetes specialist; (3) report on their last eye examination with pupil dilation; and (4) prevalence of visual impairment. RESULTS: In 2010, only 44.7% (95% CI, 27.0%-62.4%) of US adults 40 years or older with DME reported being told by a physician that diabetes had affected their eyes or that they had retinopathy; 46.7% (95% CI, 27.5%-66.0%), that they had visited a diabetes nurse educator, dietician, or nutritionist for their diabetes mellitus more than 1 year ago or never; and 59.7% (95% CI, 43.5%-75.9%), that they had received an eye examination with pupil dilation in the last year. Among persons with DME, 28.7% (95% CI, 12.7%-44.7%) were visually impaired (defined as visual acuity worse than 20/40 in the eye with DME) based on visual acuity at the initial examination and 16.0% (95% CI, 2.5%-29.4%) based on best-corrected visual acuity. CONCLUSIONS AND RELEVANCE: Many persons with diabetes mellitus in the United States are not getting care that can prevent visual impairment and blindness. Strategies to increase awareness are warranted, especially given the recent availability of improved therapies for DME.
18
Standards of Medical Care in Diabetes—2013
Diabetes Care · 2012 · 4.4K citations · Full text
Causes and Prevalence of Visual Impairment Among Adults in the UnitedStates
Archives of Ophthalmology · 2004 · 2.6K citations · Full text
Medicine, Demography, Ophthalmology +17
Ranibizumab for Diabetic Macular Edema
Quan Dong Nguyen, David M. Brown, Dennis M. Marcus et al. · Ophthalmology · 2012 · 1.6K citations
Medicine, Ophthalmology, Surgery +10
Standards of Medical Care in Diabetes 2014
Majmaah Journal of Health Sciences · 2014 · 1.5K citations · Full text
Paul Mitchell, Francesco Bandello, Ursula Schmidt‐Erfurth et al. · Ophthalmology · 2011 · 1.3K citations · Full text